FDA Brief

Warning letters Drugs

FDA warning letter to

Specialty Process Labs LLC

Issued May 3, 2022Posted May 17, 2022Division of Pharmaceutical Quality Operations IV

CGMP/Active Pharmaceutical Ingredient (API)/Adulterated. We haven't summarized this letter yet. Read it on fda.gov.

Specialty Process Labs LLC's FDA history

Recalls in the last 12 months

Jan 28 Class II Specialty Process Labs LLC
Drug
Thyroid, USP, Rx only, Net Wt: 0.50kg, For Manufacturing, Processing or Repackaging Use Only, Specialty Process Labs, Phoenix, AZ 85034, NDC 81305-100-02
Subpotent Drug

Full company page